货号 |
bs-43049P-1 |
品牌 |
|
浓度 |
|
货期 |
现货 |
英文名称 |
Recombinant SARS-Cov-2 Spike S1 protein (T19R, G142D, del157/158, L452R, T478K, D614G, P681R), His (HEK293) |
中文名称 |
Recombinant SARS-Cov-2 Spike S1 protein (T19R, G142D, del157/158, L452R, T478K, D614G, P681R), His (HEK293) |
英文别名 |
SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; Spike protein RBD; SPIKE_SARS2; 2019-nCOV Spike S1(T19R, G142D, del157/158, L452R, T478K, D614G, P681R), Recombinant (His Tag). ;Recombinant SAR |
中文别名 |
新冠病毒S蛋白; 新冠S蛋白; 新冠S1蛋白; SARS-CoV-2 S1蛋白; |
理论分子量 |
73 |
实际分子量 |
110-130 kDa |
性状 |
Lyophilized or Liquid |
纯化方法 |
AC |
SWISS |
P0DTC2 |
Gene ID |
43740568 |
保存条件 |
Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles |
Important Note |
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
英文介绍 |
The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. |
多肽活性 |
Yes |
序列 |
14-685/1273 |
标签 |
His |
纯度 |
>90% as determined by SDS-PAGE |
表达宿主 |
HEK293 cell |